CTI Life Sciences

Sign up free to access full profile and submit your pitch.

About

CTI Life Sciences is a venture capital arm of CTI BioPharma Corp., specializing in series C, seed/startup, early venture and mid venture. It invests in the pre-clinical to proof-of-concept and secondarily on proof-of-concept to Phase III stages in pharmaceutical development process. The firm seeks to invest in the life sciences sector with a focus on biotechnology, medical technology, biopharmaceuticals, drugs, drug enabling technology, and medical devices. It prefers to invest in companies based in North America with a focus on the United States and Canada specifically in Quebec and Europe. Within pre-clinical to proof-of-concept stage, the firm invests between $5 million to $15 million in the first round with pre-money between $10 million and $20 million and post-money between $15 million and $35 million with a bump up of approximately two to three times. Within proof-of-concept to Phase III stage the firm invests between $25 million to $50 million in the first round with pre-money from $50 million to more than $100 million and post-money between $75 million and $150 million with a bump-up of approximately three to five times. It seeks to exit its investments through mergers and acquisitions. CTI Life Sciences was founded in 2006 and is based in Montreal, Canada.

Investment Criteria

Other investors that have backed the same portfolio companies as CTI Life Sciences. Expand any entry to see the shared portfolio companies.

• Fonds de solidarite FTQ

  5 shared

  Shared portfolio companies

  • DalCor Pharmaceuticals Canada Inc.
  • enGene Holdings Inc.
  • Epitopea Limited
  • IMV Inc.
  • Thryv Therapeutics Inc.
• Amplitude Ventures

  4 shared

  Shared portfolio companies

  • PHEMI Systems Corporation
  • Profound Medical Corp.
  • Thryv Therapeutics Inc.
  • Zymeworks Inc.
• BDC Capital

  4 shared

  Shared portfolio companies

  • Phemi Inc.
  • PHEMI Systems Corporation
  • Profound Medical Corp.
  • Zymeworks Inc.
• Lumira Ventures

  4 shared

  Shared portfolio companies

  • enGene Holdings Inc.
  • IMV Inc.
  • Thryv Therapeutics Inc.
  • Zymeworks Inc.
• Advent Life Sciences

  2 shared

  Shared portfolio companies

  • Epitopea Limited
  • Glycomine, Inc.
• Perceptive Advisors

  2 shared

  Shared portfolio companies

  • enGene Holdings Inc.
  • Zymeworks Inc.
• Viva BioInnovator

  2 shared

  Shared portfolio companies

  • Domain Therapeutics SA
  • Phenomic AI Inc.
• Abingworth

  1 shared

  Shared portfolio companies

  • Glycomine, Inc.
• Amzak Capital Management

  1 shared

  Shared portfolio companies

  • Thryv Therapeutics Inc.
• Auriga Partners

  1 shared

  Shared portfolio companies

  • Domain Therapeutics SA